Your browser doesn't support javascript.
loading
Corrigendum: Comorbidities and outcomes of patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a real-world, nationwide, retrospective study from Hungary.
Batar, Peter; Alizadeh, Hussain; Rokszin, Gyorgy; Abonyi-Toth, Zsolt; Demeter, Judit.
Affiliation
  • Batar P; Department of Hematology, Faculty of Medicine, University of Debrecen, Debrecen, Hungary.
  • Alizadeh H; 1st Department of Medicine, Division of Haematology, Clinical Center, Medical School, University of Pecs, Pecs, Hungary.
  • Rokszin G; RxTarget Ltd., Szolnok, Hungary.
  • Abonyi-Toth Z; RxTarget Ltd., Szolnok, Hungary.
  • Demeter J; Department of Biostatistics, University of Veterinary Medicine, Budapest, Hungary.
Pathol Oncol Res ; 30: 1611758, 2024.
Article in En | MEDLINE | ID: mdl-38576767
ABSTRACT
[This corrects the article DOI 10.3389/pore.2024.1611497.].
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pathol Oncol Res Journal subject: NEOPLASIAS / PATOLOGIA Year: 2024 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Pathol Oncol Res Journal subject: NEOPLASIAS / PATOLOGIA Year: 2024 Document type: Article Affiliation country: Country of publication: